USFDA completes inspection at Gland Pharma’s API Facility in Visakhapatnam

24 May 2024 Evaluate

The United States Food and Drug Administration (USFDA) has completed an inspection at Gland Pharma’s API Facility at JNPC, Visakhapatnam from May 20, 2024 to May 24, 2024. The inspection has been completed with Zero 483 observations. 

Gland Pharma develops, manufactures and markets complex injectables. The company sells its products primarily under a business-to-business model in many countries.


Gland Pharma Share Price

1636.00 -17.35 (-1.05%)
29-Dec-2025 11:32 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.00
Dr. Reddys Lab 1262.20
Cipla 1500.00
Zydus Lifesciences 903.80
Lupin 2091.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×